02:48 , Dec 19, 2015 |  BC Extra  |  Company News

BMS divests HIV pipeline to ViiV

Bristol-Myers Squibb Co. (NYSE:BMY) said it will divest its discovery-stage, preclinical and clinical HIV assets to ViiV Healthcare, an HIV-focused JV majority-owned by GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). The companies struck separate deals for late and...